A new blood test could reveal Parkinson’s diagnoses up to seven years before symptoms emerge. Researchers from University College London and University Medical Center Goettingen in Germany used ...
Malaria continues to place a substantial burden on many emerging economies, contributing to significant loss of life, ...
– Phase III ALLEGORY study met primary and all key secondary endpoints with Gazyva, an anti-CD20 monoclonal antibody designed for enhanced B cell depletion – – Gazyva has the potential to be a ...
Researchers provide evidence that traces of the widely used PFAS chemicals in human blood are associated with unfavorable lipid profiles and thus with an increased risk of cardiovascular diseases. The ...
Alzheimer’s Disease research is advancing with developments like Roche’s new biomarker blood test. Yet 98% of AD clinical ...
The results of the Precision-T Phase 3 study of investigational allogeneic T-cell immunotherapy, Orca-T, were published in the journal Blood.
Share on Pinterest Researchers say a new blood test may be able to detect the development of Parkinson’s disease. MaaHoo/Stocksy Researchers are developing a new blood test that they say could detect ...
Please provide your email address to receive an email when new articles are posted on . Cancer survivors 65 or older exhibited higher risk for cardiovascular disease than cancer-free individuals of ...
ALZHEIMER’S disease is more widespread than previously thought, a first-of-its-kind study suggests. Using a simple blood test ...
Gastrointestinal (GI) bleeding is a symptom of a disease, condition, or injury affecting any part of the gastrointestinal tract. The GI tract includes the esophagus, stomach, small intestine, colon ...